SOA Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
HCM
AAMU
HPC
CRM
CNB
SOA Wealth Advisors's ABBV Position: Q2 2026 in Review
SOA Wealth Advisors reduced its AbbVie (ABBV) stake by 74% in Q2 2026, selling an estimated $2.84M and leaving 4,566 shares worth $276K. The position accounts for 0.05% of the portfolio, ranked #178.
SOA Wealth Advisors first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $364K in Q1 2022. 1,042 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- SOA Wealth Advisors held 4,566 shares of AbbVie worth $276K as of Q2 2026.
- SOA Wealth Advisors sold 13,215 AbbVie shares in Q2 2026, an estimated $2.84M.
- AbbVie made up 0.05% of SOA Wealth Advisors's portfolio in Q2 2026, its #178 holding.
- SOA Wealth Advisors first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
- SOA Wealth Advisors's AbbVie position peaked at $364K in Q1 2022.
- 1,042 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on SOA Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.